Ranolazine | South Africa Drug Approvals | Medicines Control Council | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ranolazine
South Africa

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Ranolazine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 27 USDMF, 15 EU WC, 2 KDMF, 22 NDC API, 35 Listed Suppliers, $ API Reference Price

56 API Suppliers
27 USDMF
15 EU WC
2 KDMF
22 NDC API
35 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

23 Intermediate Suppliers

23 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

151 FDF Dossiers, 58 FDA Orange Book, 68 Europe, 2 Canada, 3 South Africa, 20 Listed Dossiers

151 FDF Dossiers
58 FDA Orange Book
68 Europe
2 Canada
3 South Africa
20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GRANULES, EXTENDED RELEASE;ORAL - 1GM, GRANULES, EXTENDED RELEASE;ORAL - 500MG

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GRANULES, EXTENDED RELEASE;ORAL - 1GM
GRANULES, EXTENDED RELEASE;ORAL - 500MG

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 SPI Pharma, 4 DKSH, 3 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Clariant, 13 Corel Pharma Chem, 4 DFE Pharma, 10 Gangwal Chemicals, 9 Ideal Cures, 21 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Coating Systems & Additives, 32 Fillers, Diluents & Binders, 26 Controlled & Modified Release, 14 Solubilizers, 14 Direct Compression, 14 Thickeners and Stabilizers, 13 Granulation, 12 Film Formers & Plasticizers, 12 Lubricants & Glidants, 10 Parenteral, 9 Co-Processed Excipients, 7 Topical, 6 Disintegrants & Superdisintegrants, 6 Taste Masking, 6 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents, 4 Chewable & Orodispersible Aids

59 Coating Systems & Additives
32 Fillers, Diluents & Binders
26 Controlled & Modified Release
14 Solubilizers
14 Direct Compression
14 Thickeners and Stabilizers
13 Granulation
12 Film Formers & Plasticizers
12 Lubricants & Glidants
10 Parenteral
9 Co-Processed Excipients
7 Topical
6 Disintegrants & Superdisintegrants
6 Taste Masking
6 Rheology Modifiers
5 Empty Capsules
5 API Stability Enhancers
5 Emulsifying Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
4 Coloring Agents
4 Chewable & Orodispersible Aids

DIGITAL CONTENT

27 News #PharmaBuzz

27 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 18 Regulatory FDF Prices, 8 Annual Reports

19 US Medicaid Prescriptions
18 Regulatory FDF Prices
8 Annual Reports

MARKET PLACE

18 APIs, 2 FDF Dossiers

18 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

10 Others

10 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 75 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3LeBasi Pharmaceuticals (Pty) Ltd

filter Active Ingredients Reset all filters

3 All

01 3Ranolazine

filter Dosage Form Reset all filters

3 All

01 3SRT

filter Brand Name Reset all filters

3 All

01 1Ranexa 375 mg

02 1Ranexa 500 mg

03 1Ranexa 750 mg

List of Suppliers

Product Main Page

01

LeBasi Pharmaceuticals (Pty) Ltd

Country

Aus. Peptide Conference

Not Confirmed

LeBasi Pharmaceuticals (Pty) Ltd

Country

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Brand Name : Ranexa 375 mg

Dosage Form : SRT

Dosage Strength : 375mg

Packaging : 60X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

LeBasi Pharmaceuticals (Pty) Ltd

Country

Aus. Peptide Conference

Not Confirmed

LeBasi Pharmaceuticals (Pty) Ltd

Country

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Brand Name : Ranexa 500 mg

Dosage Form : SRT

Dosage Strength : 500mg

Packaging : 60X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

LeBasi Pharmaceuticals (Pty) Ltd

Country

Aus. Peptide Conference

Not Confirmed

LeBasi Pharmaceuticals (Pty) Ltd

Country

Aus. Peptide Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Originator

Registration Country : South Africa

Brand Name : Ranexa 750 mg

Dosage Form : SRT

Dosage Strength : 750mg

Packaging : 60X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!